Novo Holdings Corvus Pharmaceuticals, Inc. (CRVS) insider trading activity
Novo Holdings is > 10% Shareholder of Corvus Pharmaceuticals, Inc.. Currently has a direct ownership of 1.39 Million shares of CRVS, which is worth approximately $6.67 Million. The most recent transaction as insider was on Jul 08, 2020, when has been sold 741,440 shares (Common Stock) at a price of $5.37 per share, resulting in proceeds of $3,981,533. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.39M
0%
3M change
0%
12M change
Total Value Held
$6.67 Million
Novo Holdings Transaction History
Also insider at
NH
Novo Holdings
> 10% Shareholder
Hellerup, G7